Belgium vs Singapore: Cause of death, by non-communicable diseases, female
Belgium
75.9%
in 2021
Singapore
75.0%
in 2021
Belgium rank
60th
Singapore rank
63rd
Cause of death, by non-communicable diseases, female over time
- Belgium
- Singapore
How they compare
Belgium currently reports 75.9% against 75.0% in Singapore, a difference of 0.9%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Belgium ahead.
Belgium ranks 60th and Singapore ranks 63rd of 185 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Belgium | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.7% | 80.9% | 5.8% | Belgium |
| 2010s | 86.0% | 74.7% | 11.3% | Belgium |
| 2020s | 72.9% | 75.6% | 2.7% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Belgium or Singapore?
- Belgium, at 75.9% against 75.0% in Singapore as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Belgium and Singapore?
- 0.9%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and Singapore rank globally for cause of death, by non-communicable diseases, female?
- Belgium ranks 60th and Singapore ranks 63rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.